Skip to content

Combining Non-invasive Brain Stimulation and Exercise to Treat Low Back Pain

Repetitive Transcranial Magnetic Stimulation Alone and in Combination With Motor Control Exercise for the Treatment of Patients With Chronic Non-specific Low Back Pain (ExTraStim Trial): Study Protocol for a Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04555278
Enrollment
140
Registered
2020-09-18
Start date
2020-09-25
Completion date
2024-03-01
Last updated
2026-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Low-back Pain

Keywords

Transcranial Magnetic Stimulation, Motor Control Exercises, Randomized Controlled Trial

Brief summary

The aim of this study is to evaluate the efficacy of repetitive transcranial magnetic stimulation alone and in combination with motor control exercises on pain and disability for patients with chronic non-specific low back pain.

Interventions

DEVICEActive rTMS

A figure-of-8 coil connected to a biphasic Magstim Rapid 2 stimulator (The MagstimCo, Whitland, UK) will be used. Coil orientation and position will be guided throughout the experiment by a neuronavigation system (Brainsight, Rogue research, Montreal, QC, Canada). The intensity of rTMS will be set at 95 % of the first dorsal interosseous (FDI) resting motor threshold (RMT). Active rTMS will consist of 40 trains of 5 seconds each at 10 Hz (25-s intertrain interval) applied over M1 (on FDI cortical representation), for a total of 2000 stimulations lasting 20 minutes.

DEVICESham rTMS

A sham coil will be use (e.g. equipped with a magnetic shield that blocks the magnetic field). The sham stimulation will last the same duration as the active rTMS (30 min).

The rehabilitation program will consist of a 30-minute session of motor control exercises following the rTMS (Active or Sham) intervention. This approach aims to improve spine health through the optimization of spine loading. The first session will be preceded by an individualized evaluation of the participant's abilities and deficiencies to tailor the training program to each participant.

Sponsors

Hugo Massé-Alarie
Lead SponsorOTHER
Pfizer
CollaboratorINDUSTRY
The Canadian Pain Society
CollaboratorOTHER
Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Participants will be masked to rTMS intervention (real or sham) but cannot be blinded to the exercise intervention. However, participants will not be aware of the study design (other arms). Therapist delivering the exercise intervention will be masked to rTMS intervention (active vs. sham) but cannot be blinded to exercise intervention (yes vs. no). Experimenter delivering the rTMS intervention will be masked to exercise intervention but not to rTMS intervention (real or sham). Outcomes assessor will be completely masked to all interventions as all outcomes are questionnaires that will be completed online. Data will be de-identified and the data analyst will be masked to participants and group allocation.

Intervention model description

Pseudo-factorial design (rTMS: Active/Sham \| Exercises: Yes/No)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* chronic low back pain, defined as "pain in the low back area with or without leg pain above the knee limiting activities or daily routine which has been present for more than 3 months"; * a minimal average pain intensity of 3 out of 10 during the preceding week on a pain numerical rating scale; * a minimal score of 10 points on the Oswestry disability index (ODI).

Exclusion criteria

* specific spinal pathology (fracture, tumor, radiculopathy, spinal infection, etc.); * a history of back surgery; * a major orthopedic, neurological, cardiovascular or psychiatric illness; * low back pain is not the main pain complaint; * currently using an exercise program to treat their LBP; * presenting with any specific TMS/rTMS-related

Design outcomes

Primary

MeasureTime frameDescription
Pain intensity (average pain over the last week)Change from baseline to 4 weeks, 8 weeks, 12 weeks and 24 weeksPain score on a 11-point pain numerical rating scale (PNRS) ranging from 0 to 10, with 0 meaning no pain and 10 the worst pain imaginable.

Secondary

MeasureTime frameDescription
Disability (ODI)Change from baseline to 4 weeks, 8 weeks, 12 weeks and 24 weeksThe Oswestry Disability Index (ODI) version 2.1 is a self-completed questionnaire giving a subjective percentage score of disability. Includes 10 questions rated on a 6-item scale, from 0 to 5 points. The total score ranges from "0" (No disability) to "100" (Maximal disability).
Tampa scale of kinesiophobia (TSK)Change from baseline to 8 weeks, 12 weeks and 24 weeksTSK is used to assess pain-related fear of movement with a 17-item questionnaire. Each item is scored on a 4-point Likert scale. Total score ranges from 17 (minimal pain-related fear of movement) to 58 (maximal pain-related fear of movement).
Global rating of changeChange from baseline to 8 weeksA 11-point scale ranging from -5 to 5, to evaluate the perceived change of health status after the intervention.

Countries

Canada

Contacts

PRINCIPAL_INVESTIGATORHugo Massé-Alarie, PhD

Laval University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026